-
It’s crucial to not overlook quality of life when treating patients with rare diseases
Read why emerging therapies for pulmonary hypertension, and how they impact patient quality of life, have researchers and pharmaceutical companies asking, “Is it worth investing in?”: #ERDC2018 – When Treating Rare Disease Patients, Don’t Overlook Quality of Life, Panel Urges
How have the treatments you tried impacted your quality of life? On a scale of 1-10, how important is quality of life to you, versus treatment effectiveness?
Sorry, there were no replies found.
Log in to reply.